C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/32 (2006.01) A61K 31/4965 (2006.01) A61K 31/497 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01) C07D 403/12 (2006.01) C07D 451/04 (2006.01)
Patent
CA 2630889
A compound of formula (I) or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, T, L, W, X, Y and A are as defined herein for the for treatment of conditions mediated by the blockade of an epithelial sodium channel, particularly an inflammatory or allergic condition.
La présente invention concerne un composé de formule (I) ou des tautomères, ou stéréoisomères, ou solvates, ou des sels pharmaceutiquement acceptables de ceux-ci, dans laquelle R1, R2, R3, R4, R5, T, L, W, X, Y et A sont tels que définis dans la description pour le traitement de conditions liées au blocage du canal sodique épithélial, notamment une pathologie inflammatoire ou allergique.
Collingwood Stephen Paul
Cox Brian
Legrand Darren Mark
Smith Nichola
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Pyrazine derivatives as epithelial sodium channel blocker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazine derivatives as epithelial sodium channel blocker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazine derivatives as epithelial sodium channel blocker will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1924592